CancerIQ integrates real-time clinical and genomics data to empower oncologists, administrators, researchers and patients to build better intelligence in cancer. Our technology platform identifies patients who would benefit from genetically-informed care, interprets a growing number of cancer-specific variables, and highlights the best evidence-based interventions.
CancerIQ helps manage the complexity of genomic medicine and empowers oncologists everywhere to deliver premium personalized cancer care.
For clinical researchers to identity study subjects, manage data, and engage with patients
For oncologists to identify patient risks, improve treatment decisions, and monitor patients long-term
For administrators to identify risks, monitor quality, and develop business intelligence
For patients to engage with their care team, play a more active role in evaluating treatment options, and to monitor their chronic condition long-term.
Identify, understand, and manage genetic risks in cancer over time while increasing adherence to the latest guidelines in genomic medicine.
Reduce the number of administrative, nursing, and genetic counseling staff needed to deliver personalized cancer care.
Identify new patterns in genomic medicine.
Secure brokered data sharing between academic and commercial researchers.
In 2006, the big data platform used by CancerIQ today was developed at the University of Chicago by an interdisciplinary team of researchers. This effort was led by Dr. Olufunmilayo Olopade, a MacArthur Foundation Genius award-winning cancer geneticist, and by Dr. Ian Foster, Director of the Computational Institute and the "father" of grid computing.
This technology was optimized specifically for cancer, and supports the integration of clinical genomics and outcomes data. This allowed researchers and oncologists to quickly develop insights that would have otherwise been trapped in various IT systems and data warehouses. Researchers at the University of Chicago were able to use this large repository of high quality data on cancer cases to improve research productivity and accelerate discovery.
The CancerIQ team was formed in 2012 to scale access to this valuable technology. As a separate commercial entity, CancerIQ can now share the University of Chicago's data-driven approach with researchers, oncologists, administrators and patients, to accelerate personalized care in cancer.
Feyi Olopade -
Chief Executive Officer
Haibo Lu -
Chief Technology Officer
Paul Fung -
VP of Engineering
Kisha Hope -
Chief Operations Officer
Chief Medical Advisor
Lauren Post -
Business Development and
Technology - Ian Foster, PhD Director of the Computational Institute, University of Chicago Distinguished Fellow, Argonne National Labs
Informatics - Edward Shortliffe, MD, PhD Former CEO, American Medical Informatics Association
Informatics - Jonathan Silverstein, MD Director, Clinical Informatics NorthShore University Health System
Patient Adocacy - Shirley Mertz President of the Metastatic Breast Cancer Network, Chair of Patient Advocate Committee, Translational Breast Cancer Research Consortium
Strategy/Marketing - Nancy Harvey, MBA Former CEO Wolfram Research, Former Executive VP Health Care Group, Computer Sciences Corporation
Information CancerIQ May Collect From You We collect the information needed to provide Cancer-IQ.com visitors with the information, products, and services that Site visitors request and to update, promote, and distribute our products and services as they evolve.We collect the following information:
We use the web log information to help us design our Site, to identify popular features, and to make the Site more useful for our visitors. Web logs are recorded in sequential files, and we do not try to identify individuals from web logs or use web logs to gather information about individuals. However, we may use web logs to identify any person attempting to break into or damage the Site, and we may share web log information with law enforcement agencies if we believe that we have evidence of a violation of computer security or related laws.
Customer or Visitor Requests for Information: If you ask a question or make a request through this web site or email, we may store your message and our response for a period of time. We may use the information that we collect from your correspondences to respond to your inquiry and/or to notify you of various products and services, events, news or other CancerIQ-related opportunities or those of our partners. Email addresses and other contact information is never sold, given, or otherwise shared or disclosed to third parties except as expressly set forth herein. We respect your right to make choices about the ways we collect, use and disclose your personal information. You may change your email preferences relating to promotional communications emails from us by following the instructions at the bottom of those emails. Opt-out requests will not apply to transactional service communications including, but not limited to, messages about your registration.
We do not sell or lease personal information about visitors to this Site. We do not use or disclose personal information obtained through this Site except as expressly described in this policy. Notwithstanding the foregoing, we may reveal personally identifiable information about you to third-parties if: (a) the information is provided to comply with the law, enforce an agreement we have with you, or to protect our rights, property or safety, or the rights, property, or safety of our employees or others; or (b) the information is provided to our agents, vendors, or service providers who perform functions on our behalf as described below.
We may disclose personal information to any person performing audit, legal, operational, or other services for us. Whenever possible, we will require any recipient of personal information for these purposes to agree in writing to use the information only for the purpose for which it was disclosed and to destroy or return it when no longer needed for that purpose. We may disclose personal information when required to do so by a subpoena, court order, or search warrant. Except when deemed by us to be infeasible, we will notify the individual of a subpoena, court order, or search warrant for the individual information, by e-mail using the e-mail address (if any) that the individual provided to us.
We may disclose personal information, as we deem appropriate, to protect the safety of an individual or for an investigation related to public safety or to report an activity that appears to be in violation of law. We may disclose personal information to protect the security and reliability of this web Site, and to take precautions against liability. We may disclose personal information to any successor in interest (any company or organization that purchases or otherwise take control of our assets).
CancerIQ is not a health plan, health care provider, or health care clearinghouse as defined in the Health Insurance Portability and Accountability Act of 1996 and its related regulations set forth in Parts 160, 162, and 164 of Title 45 of the Code of Federal Regulations (collectively, “HIPAA”) and CancerIQ is not acting on behalf of a one of those entities as the operator of the Site. For more information on our compliance with HIPAA, please visit our HIPAA Policy.
Customers of CancerIQ’s products and services may use the sections of the Cancer-IQ.com Site reserved for customer use that require a login solely as their respective agreements permit. Other authorized users may use them solely as and to the extent they have been authorized to do so. We request information from customers and other authorized users to authenticate them and verify their authorized use of the products, services, and other resources that CancerIQ provides.
We do not sell products or services to children. If you are under 18, you may use this site only with involvement of a parent or guardian.
If you have any questions, comments, or concerns regarding this Policy, please contact us by email at firstname.lastname@example.org
This Notice is effective as of September 24, 2013.
CancerIQ, Inc. and its affiliates (individually and collectively, “we”, “our”, “us”, or “CancerIQ”) designed and maintain www.cancer-iq.com (the “Site”) as a means of providing information regarding our company and various products and services that we sell primarily within the United States. As used on the Site, the terms “you” and “your” means any person who views, accesses, uses, or obtains information from the Site or who obtains information by monitoring activity to and from the Site.
You will access and use the Site solely for your personal purposes. You will not post, publish, reproduce, transmit, distribute or otherwise view, use or exploit the Site or any Content in a manner that: (1) is inconsistent with this Agreement; (2) violates any federal, state or local law, rule, regulation or order, or (3) could damage, disable, overburden, or impair the Site or interfere with any other party’s use and enjoyment of the Site. You acknowledge and agree that the Site and the Content includes subject matter that is owned by us or other third parties and is protected under copyright, trademark and other intellectual property laws. Unauthorized use of the Site or the Content may violate such intellectual property laws or other laws relating to privacy and publicity. The violation of such laws may give rise to civil and/or criminal penalties.
You agree that you will not interrupt or attempt to interrupt the operation of this Site in any way. You will not impersonate any person or entity, or misrepresent your affiliation with a person or entity, or misrepresent the origin of any information that you provide to us. You agree that your use of the Site will at all times be for a lawful purpose and you agree to comply with all applicable laws and regulations in your use of the Site. Possible evidence of use of this Site for illegal purposes may be provided to law enforcement authorities.
You will not transmit, distribute, introduce or otherwise make available in any manner through the Site any computer virus, keyloggers, spyware, worms, Trojan horses, time bombs or other malicious or harmful programming (collectively, “Malware”). We do not have an obligation to detect the presence of such Malware. If you download software or any other Content from the Site, you do so at your own risk.
You acknowledge that this Site and various elements contained therein are protected by copyrights, trademarks, trade secrets, patents, or other proprietary rights, and that these worldwide rights are valid and protected in all forms, media, and technologies existing now and hereinafter developed. You also acknowledge that the Content is and shall remain our property or the property of our licensors. You agree to comply with all intellectual property laws and you shall not encumber any interest in, or assert any rights to, the Content. You may not modify, transmit, participate in the sale or transfer of, or create derivative works based on any Content, in whole or in part. However, you may print a reasonable number of copies of the Content for your personal use provided that you maintain any notices contained in the Content, such as all copyright notices, trademark legends, or other proprietary rights notices.
The trademarks, logos and service marks appearing on this Site, including, but not limited to, the trademarks: “CancerIQ,” "www.cancer-iq.com", are trademarks and service marks of CancerIQ, Inc. Other company, product, and service names and logos used and displayed on this Site may be trademarks or service marks of their respective owners who may or may not endorse or be affiliated with or connected to us. Nothing on this Site should be construed as granting, by implication or otherwise, any license or right to use any of trademarks and service marks displayed on this Site, without our prior written permission in each instance.
The Content of this Site is protected by copyright law. All such Content is also copyrighted as a collective work under the copyright laws, and we own a copyright in the selection, coordination, arrangement, and enhancement of such Content.
If you believe this Site contains Content that infringes your copyright, please contact email@example.com and provide information related to your claim of copyright infringement.
Please be advised that we cannot guarantee the confidentiality of any communication or material transmitted to us via the Site or via electronic mail. Accordingly, we suggest that you use caution when transmitting any information to us via such means. For example, you should not include confidential information about you (such as your Social Security number) in any email that you send to us. We hereby expressly disclaim any liability for damages resulting from third party interception of your communications with us via the Site or via electronic mail. If you choose to send us any information via the Site or via e-mail, you do so solely at your own risk.
Unless we specifically provided otherwise, all feedback or submissions of any kind that you submit to this Site (the “Contributions”) are hereby received on a non-confidential basis and shall, to the fullest extent permissible under applicable law, become our property. To the extent that applicable law does not provide us with an ownership interest in any Contributions, you agree that by providing us with the Contributions you are granting us any of our affiliated companies and sublicensees a perpetual, royalty-free, irrevocable worldwide license to use, transmit, copy, reproduce, distribute, publicly display or perform, and to prepare derivate works based upon the Contributions. By submitting or otherwise making the Contributions available to us, you represent and warrant that you own or control all rights in such Contributions necessary to post, upload, input, submit or otherwise make them available to us, and to provide us with either ownership or licensed rights under this section of the Agreement. You understand that your Contributions will not be confidential and that no compensation will be paid to you with respect to your Contributions. Despite the rights granted to us herein, we are under no obligation to in any way use, post, or otherwise make such Contributions available.
We prohibit the use of any links to the Site from any other websites unless establishment of such a link is approved in advance by us in writing. You may not frame any elements of this Site with any other website without our prior written permission.
This Site may periodically provide links to third-party websites (“Third-Party Sites”). This Agreement governs only this Site and not any Third-Party Sites. Our decision to link to a Third-Party Site is not an endorsement of the content, products or services in the Third-Party Site. We do not control these Third-Party Sites and expressly disclaims any responsibility for the content, the accuracy of the information and any products or services available on the Third-Party Sites. We have not investigated or monitored the Third Party Sites for accuracy or completeness. The Third Party Sites may have different privacy policies and security standards than our Site. We are not responsible if any terms shown on our Site differ from those shown on the Third-Party Sites. If you decide to access linked Third-Party Sites, you do so at your own risk.
We protect your privacy related to this Site. We maintain appropriate administrative and technical controls to safeguard the security and privacy of your personal information. Disclaimer of Warranties
YOU ACKNOWLEDGE AND AGREE THAT THIS SITE IS PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS. NONE OF CANCERIQ, ITS AFFILIATES, SUBSIDIARIES OR ITS OR THEIR OFFICERS, DIRECTORS, EMPLOYEES OR AGENTS (COLLECTIVELY THE “CANCERIQ PARTIES”) GUARANTEES THE ACCURACY, COMPLETENESS, TIMELINESS, RELIABILITY, SUITABILITY OR USEFULNESS OF ANY PORTION OF THE SITE. NONE OF THE CANCERIQ PARTIES WARRANT THAT THIS SITE WILL BE UNINTERRUPTED OR ERROR FREE, THAT ANY SPECIFIC INFORMATION THAT IS REQUESTED WILL BE PROVIDED OR THAT THIS SITE OR ITS SERVER ARE OR WILL BE FREE OF COMPUTER VIRUSES OR OTHER HARMFUL ELEMENTS. YOU EXPRESSLY AGREE THAT THE ENTIRE RISK AS TO THE QUALITY AND PERFORMANCE OF THIS SITE AND THE ACCURACY, TIMELINESS OR COMPLETENESS OF THE CONTENT OR SERVICES IS ASSUMED SOLELY BY YOU.
NONE OF THE CANCERIQ PARTIES MAKES ANY, AND HEREBY SPECIFICALLY DISCLAIMS ANY AND ALL, REPRESENTATIONS, ENDORSEMENTS, GUARANTEES, AND WARRANTIES, EXPRESS OR IMPLIED, REGARDING THIS SITE, INCLUDING WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, TITLE AND NON-INFRINGEMENT OF THIRD-PARTY RIGHTS. YOU UNDERSTAND AND AGREE THAT ANY CONTENT, MATERIAL AND/OR DATA DOWNLOADED OR OTHERWISE OBTAINED THROUGH THE USE OF THE SITE IS USED AT YOUR OWN RISK AND THAT YOU WILL BE SOLELY RESPONSIBLE FOR ANY DAMAGE TO YOUR COMPUTER SYSTEM OR LOSS OF DATA THAT RESULTS FROM THE DOWNLOAD OF SUCH CONTENT, MATERIAL AND/OR DATA.
UNDER NO CIRCUMSTANCES WILL ANY OF THE CANCERIQ PARTIES BE LIABLE FOR ANY LOSS OR DAMAGE CAUSED BY YOUR RELIANCE ON INFORMATION OBTAINED THROUGH THIS SITE. IT IS YOUR RESPONSIBILITY TO EVALUATE THE ACCURACY, COMPLETENESS, OR USEFULNESS OF THIS SITE. IN NO EVENT SHALL ANY OF THE CANCERIQ PARTIES BE LIABLE FOR ANY DIRECT, INDIRECT, PUNITIVE, INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR RELATING TO THE SITE OR THIS AGREEMENT, WHETHER BASED ON WARRANTY, CONTRACT, TORT, OR ANY OTHER LEGAL THEORY. BECAUSE SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR NEGLIGENCE, CONSEQUENTIAL, INCIDENTAL OR OTHER DAMAGES, IN SUCH JURISDICTIONS THE CANCERIQ PARTIES’ LIABILITY IS LIMITED TO THE GREATEST EXTENT PERMITTED BY LAW. YOUR SOLE REMEDY FOR DISSATISFACTION WITH THIS SITE IS TO STOP USING THIS SITE.
This Agreement and all matters relating to your access to, or use of this Site shall be governed by and construed in accordance with the laws of the State of New York, USA, without giving effect to conflict of law principles. We make no representation that the Content on our Site is appropriate, legal or available for use in other locations. Those who choose to access this Site from other locations do so at their own initiative and are responsible for compliance with applicable local laws.
Any legal action or proceeding relating to this Agreement or your access to or use of this Site shall be instituted in a state or federal court in the State of New York. You agree to submit to the jurisdiction of, and agree that venue is proper in these courts. You agree to make the CancerIQ Parties whole for any and all claims, losses, liabilities, and expenses (including attorneys’ fees) arising from your use of the Site or any violation of this Agreement.
If we have provided you with a translation of the English language version of this Agreement, then you agree that the translation is provided for your convenience only and that the English language versions of the Agreement will govern your relationship with CancerIQ. If there is any contradiction between what the English language version of the Agreement says and what a translation says, then the English language version shall take precedence.
If you allow your minor child or a child for whom you are a legal guardian (a “Minor”) to access the Site, you will be solely responsible for (i) the online conduct of such Minor, (ii) monitoring such minor’s access to and use of the Site, and (iii) the consequences of any use of the Site by such Minor.
We do not intend to solicit information or to market any products or services to children through this Site. Pursuant to 47 U.S.C. § 230(d) as amended, we hereby notify you that parental control protections (such as computer hardware, software, or filtering services) are commercially available that may assist you in limiting access to material and information that is harmful to Minors.
In the event that any portion of this Agreement is held to be invalid or unenforceable, then such portion shall be construed in accordance with the applicable law as nearly as possible to reflect the original intentions of the parties, and the remainder of this Agreement shall remain in full force and effect. The sections of this Agreement entitled Intellectual Property Rights, Disclaimer of Warranties, Limitation of Liability, Governing Law; Disputes and Miscellaneous shall survive the termination of this Agreement. This Agreement contains the entire agreement of the parties concerning your use of this Site and supersedes all existing agreements and all other oral, written or other communication between the parties concerning its subject matter. We reserve the right to change, suspend, or discontinue all or any part of this Site or the Content at any time without prior notice or liability. You expressly absolve and release the CancerIQ Parties from any claim of harm resulting from a cause beyond their control, including, but not limited to, failure of electronic or mechanical equipment or communication lines, telephone or other interconnect problems, computer viruses, unauthorized access, theft, operator errors, severe weather, earthquakes, or natural disasters, strikes or other labor problems, wars, terrorist activities or governmental restrictions. You may not assign this Agreement. No waiver shall be effective unless in writing. The paragraph headings herein are provided only for reference and shall have no effect on the construction or interpretation of this Agreement. You expressly agree not to export or re-export any of the Content to countries or persons prohibited under the export control laws of the United States.
This Notice is effective as of September 24, 2013.
NOTICE OF PRIVACY PRACTICESTHIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.
Cancer IQ, Inc. (“Cancer IQ”) is committed to obtaining, maintaining, using and disclosing patient protected health information in a manner that protects patient privacy. We urge you to read this Notice of Privacy Practices (“Notice”) carefully in order to understand both our commitment to the privacy of your protected health information and your rights.
Cancer IQ is required by law to maintain the privacy of your protected health information and to provide you with a notice of our legal duties and privacy practices with respect to protected health information. This Notice describes how we may use and disclose your protected health information to carry out treatment, payment or health care operations and for other specified purposes that are permitted or required by law. The Notice also describes your rights with respect to your protected health information. "Protected health information" or "PHI" is information about you, including basic demographic information, that may identify you and that relates to your past, present or future physical or mental health or condition and related health care services.
We are required to follow the terms of this Notice. We will not use or disclose your protected health information without your written permission, except as described in this Notice. We reserve the right to change our practices and this Notice as and to the extent permitted by law and to make a new Notice effective for all protected health information we maintain. Upon your request, we will provide you with a revised Notice.
Examples of How We Use and Disclose Protected Health Information About You
Your PHI may be used and disclosed for treatment, payment, healthcare operations, and other purposes permitted or required by law. If we wish to use or disclose your PHI for other purposes, we would have to obtain your written authorization. Cancer IQ may, however, use or disclose your PHI without specific authorization or permission for certain purposes, including:Treatment: Cancer IQ may use your health information to provide and coordinate the treatment and services you receive. For example, we may use your information to perform diagnostic tests, or provide your test results to your physician.
Cancer IQ may use and disclose your health information to others for purposes of receiving payment for treatment and services that you receive. For example, we will submit a claim to you or your health plan/insurer that includes information that identifies you and the type of services we performed for you.
Cancer IQ may use or disclose your PHI in order to support the operations of our laboratories and monitor the quality of the services we provide. For example, we may use information in your health record to evaluate the services our laboratories provide or to train our staff. In addition, we may contact you as part of a fundraising effort.
Minors’ Protected Health Information: As permitted by federal and state law, we may disclose PHI about minors to their parents or guardians. Business Associates: There are some services provided by Cancer IQ through contracts with business associates (e.g., billing services), and we may disclose your PHI to our business associate so that they can perform the job we have asked them to do. To protect your information, however, we require the business associate to appropriately safeguard your information. Food and Drug Administration (FDA): We may disclose to the FDA, or persons under the jurisdiction of the FDA, PHI relative to adverse events with respect to drugs, foods, supplements, products and product defects, or post marketing surveillance information to enable product recalls, repairs, or replacement.
Worker's Compensation: We may disclose your PHI to the extent authorized by and to the extent necessary to comply with laws relating to worker's compensation or other similar programs established by law. Public Health: As required by law, we may disclose your PHI to public health or legal authorities chafrged with preventing or controlling disease, injury, or disability. Law Enforcement: We may disclose your PHI for law enforcement purposes as permitted by law or in response to a valid subpoena or court order. As Required by Law: We will disclose your PHI when required to do so by federal, state, or local law.
Health Oversight Activities: We may disclose your PHI to an oversight agency for activities authorized by law. These oversight activities include audits, investigations, and inspections necessary for licensure and for the government to monitor the health care system, government programs, and compliance with civil rights laws.
Judicial and Administrative Proceedings: If you are involved in a lawsuit or a dispute, we may disclose your PHI in response to a court or administrative order. We may also disclose PHI in response to a subpoena, discovery request, or other lawful process by someone else involved in the dispute, but only if efforts have been made, either by the requesting party or by us to tell you about the request or to obtain an order protecting the information requested.
We may disclose your PHI to researchers when their research has been approved by an institutional review board or privacy board that has reviewed the research proposal and established protocols to ensure the privacy of your information.
We may release your PHI to a coroner or medical examiner. This may be necessary, for example, to identify a deceased person or determine the cause of death. We may also disclose PHI to funeral directors consistent with applicable law to enable them to carry out their duties.
We may use or disclose your PHI to notify or assist in notifying a family member, personal representative, or another person responsible for your care, regarding your location and general condition. Correctional Institution: If you are or become an inmate of a correctional institution, we may disclose to the institution or its agents PHI necessary for your health and the health and safety of other individuals. To Avert a Serious Threat to Health or Safety: We may use and disclose your PHI when necessary to prevent a serious threat to your health and safety or the health and safety of the public or another person. Military and Veterans: If you are a member of the armed forces, we may release PHI about you as required by military command authorities. We may also release PHI about foreign military personnel to the appropriate foreign military authority.
Specialized Government Functions: Under certain circumstances, we may disclose your PHI to units of the government with specialized functions such as the U.S. Military or the U.S. Department of State in response to requests as authorized by law.
We may disclose PHI about you to a government authority if we reasonably believe you are a victim of abuse or neglect. We will only disclose this type of information to the extent required by law, if you agree to the disclosure, or if the disclosure is allowed by law and we believe it is necessary to prevent serious harm to you or someone else.
We will obtain your written authorization before using or disclosing your PHI for purposes other than those provided for above (or as otherwise permitted or required by law). You may revoke this authorization in writing at any time. Upon receipt of the written revocation, we will stop using or disclosing your PHI, except to the extent that we have already taken action in reliance on the authorization.
Obtain a paper copy of the Notice upon request. You may request a copy of our current Notice at any time from the Privacy Officer. Even if you have agreed to receive the Notice electronically, you are still entitled to a paper copy.
Request a restriction on certain uses and disclosures of PHI. You have the right to request additional restrictions on our use or disclosure of your PHI by sending a written request to Cancer IQ's Privacy Officer. We are not required to agree to those restrictions.
Inspect and obtain a copy of PHI. By law, a patient generally has the right to access and copy his/her PHI. However, PHI that is maintained by entities that are subject to the Clinical Laboratory Improvement Amendments of 1988 ("CLIA") is specifically exempted from the right to access, to the extent the provision of access to the patient would be prohibited by law. Since Cancer IQ is subject to CLIA, the applicable state law provisions may restrict your right to access and copy your PHI. If state law permits access, to inspect and copy your PHI, you must send a written request to the Privacy Officer. We may charge you a fee for the costs of copying, mailing and supplies that are necessary to fulfill your request. We may deny your request to inspect and copy in certain limited circumstances.
Request an amendment of PHI. If you feel that PHI we maintain about you is incomplete or incorrect, you may request that we amend it. To request an amendment, you must send a written request to the Privacy Officer. You must include a reason that supports your request. In certain cases, we may deny your request for amendment. For example, in circumstances under which the patient would be denied access to his/her PHI, we may deny a request for amendment.
Receive an accounting of disclosures of PHI.
You have the right to receive an accounting of the disclosures we have made of your PHI for purposes other than treatment, payment, healthcare operations, and certain other activities. The right to receive an accounting is subject to certain exceptions, restrictions, and limitations. To request an accounting, you must submit a request in writing to the Privacy Officer. Your request must specify the time period for which you would like an accounting, but this time period may not be longer than six years.
Request communications of PHI by alternative means or at alternative locations. You have a right to request to receive communications of PHI by alternate means or at alternate locations. For instance, you may request that we contact you about medical matters only in writing or at a different residence or post office box. To request confidential communication of your PHI, you must submit a request in writing to the Privacy Officer. Your request must state how or where you would like to be contacted. We will accommodate all reasonable requests.
For More Information or to Report a Problem
If you have questions or would like additional information about our privacy practices, you may contact:
Cancer IQ, Inc. Privacy Officer 222 W. Merchandise Mart Plaza, 12th Floor Chicago, Illinois 60654
If you believe your privacy rights have been violated, you can file a complaint with the Privacy Officer or with the United States Secretary of Health and Human Services. There will be no retaliation for filing a complaint.
This Notice is effective as of September 18, firstname.lastname@example.org
Cancer IQ has proven results. Our technology empowers healthcare providers with the financial information they need, leading to increased revenue, improved employee performance and enhanced patient satisfaction.
When you request a demo, our unmatched customer service team will reach out within 24 hours to walk you through each step of our technology. Simply fill out the contact form below.